MangoRx Review
Best for: pending product verification
MangoRx (Mangoceuticals) is a men's health telehealth platform offering compounded GLP-1 weight management alongside testosterone replacement therapy, ED treatment, and hair loss programs. Stub entry pending YMYL verification of the GLP-1-specific offering — pricing, states, pharmacy partners, and clinical workflow.
Low confidence · Last verified 2026-04-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
MangoRx is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
MangoRx prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Preliminary | compounded | $199 |
✓ Pros
- •Katalys-approved program at 14% commission — attractive on higher AOV orders
- •Men's-health-focused telehealth — bundled GLP-1 + TRT + ED + hair lets a single user fill multiple needs through one provider
✗ Cons
- •Stub entry — exact GLP-1 drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- •Confidence is LOW until that pass is done
- •Cross-selling TRT alongside GLP-1s is editorially worth disclosing — readers looking specifically for weight loss may not want to be funneled into a men's-hormone broader program
Ready to start with MangoRx?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our MangoRx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to MangoRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with MangoRx?
Starting at $199/month. See current pricing and start your free consultation.